PAR 0.00% 19.5¢ paradigm biopharmaceuticals limited..

PAR, the Moat and a Recipe for success, page-4

  1. 1,656 Posts.
    lightbulb Created with Sketch. 177
    This below originally posted by Edski. Looks pretty simple
    procedure with very solid results. Don’t see why it
    would be very expensive.

    Hello all. Interesting article by Blokey above. Always good to see others discussion regarding Paradigm and investment thoughts.

    In digging around for Paradigm related information, I come across some other trials for treatments of OA. I thought that I would share a few of these with you, to keep you guessing how or if anothernon opioidmedical treatment will compare to Zilusol:

    American Journal of Sports Medicine Publishes Results of an FDA-Approved Clinical Trial Treating Osteoarthritis Knee Pain



    Clinical Efficacy of Intra-articular Mesenchymal Stromal Cells for the Treatment of Knee Osteoarthritis: A Double-Blinded Prospective Randomized Controlled Clinical Trial - Jaime R. Garza, Richard E. Campbell, Fotios P. Tjoumakaris, Kevin B. Freedman

 
watchlist Created with Sketch. Add PAR (ASX) to my watchlist
(20min delay)
Last
19.5¢
Change
0.000(0.00%)
Mkt cap ! $68.29M
Open High Low Value Volume
19.5¢ 20.5¢ 19.0¢ $156.2K 795.1K

Buyers (Bids)

No. Vol. Price($)
7 152244 19.5¢
 

Sellers (Offers)

Price($) Vol. No.
20.0¢ 25584 1
View Market Depth
Last trade - 16.10pm 01/10/2024 (20 minute delay) ?
PAR (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.